Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-01-09

Clinical Trial Update: A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study of Boceprevir with amlodipine or diltiazem in healthy volunteers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Boceprevir (boceprevir)
  • Diltiazem (diltiazem)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Hepatitis C, Hypertension | Phase 1 | Status: WITHDRAWN